Global Neuromodulation Devices and Implantable Infusion Pumps Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Neuromodulation Devices and Implantable Infusion Pumps

• 1.1 Definition of Neuromodulation Devices and Implantable Infusion Pumps
• 1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
  • 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Neuromodulation Devices
  • 1.2.3 Implantable Infusion Pumps
• 1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Applications
  • 1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
• 1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Overall Market
  • 1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (2014-2025)
  • 1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Production (2014-2025)
  • 1.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
  • 1.4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
  • 1.4.5 China Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
  • 1.4.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
  • 1.4.8 India Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
• 2.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
• 2.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps

3 Development and Manufacturing Plants Analysis of Neuromodulation Devices and Implantable Infusion Pumps

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Neuromodulation Devices and Implantable Infusion Pumps
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Neuromodulation Devices and Implantable Infusion Pumps Production and Capacity Analysis
• 4.2 Neuromodulation Devices and Implantable Infusion Pumps Revenue Analysis
• 4.3 Neuromodulation Devices and Implantable Infusion Pumps Price Analysis
• 4.4 Market Concentration Degree

5 Neuromodulation Devices and Implantable Infusion Pumps Regional Market Analysis

• 5.1 Neuromodulation Devices and Implantable Infusion Pumps Production by Regions
  • 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production by Regions
  • 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions
• 5.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
• 5.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Import and Export
• 5.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Import and Export
• 5.5 China Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.5.1 China Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.5.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Neuromodulation Devices and Implantable Infusion Pumps Import and Export
• 5.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.6.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.6.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Import and Export
• 5.7 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.7.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.7.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Import and Export
• 5.8 India Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
  • 5.8.1 India Neuromodulation Devices and Implantable Infusion Pumps Production
  • 5.8.2 India Neuromodulation Devices and Implantable Infusion Pumps Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Neuromodulation Devices and Implantable Infusion Pumps Import and Export

6 Neuromodulation Devices and Implantable Infusion Pumps Segment Market Analysis (by Type)

• 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production by Type
• 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
• 6.3 Neuromodulation Devices and Implantable Infusion Pumps Price by Type

7 Neuromodulation Devices and Implantable Infusion Pumps Segment Market Analysis (by Application)

• 7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
• 7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2014-2019)

8 Neuromodulation Devices and Implantable Infusion Pumps Major Manufacturers Analysis

• 8.1 Advanced Bionics/Sonova
  • 8.1.1 Advanced Bionics/Sonova Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.1.2 Advanced Bionics/Sonova Product Introduction, Application and Specification
  • 8.1.3 Advanced Bionics/Sonova Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Cerbomed
  • 8.2.1 Cerbomed Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.2.2 Cerbomed Product Introduction, Application and Specification
  • 8.2.3 Cerbomed Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Cochlear
  • 8.3.1 Cochlear Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.3.2 Cochlear Product Introduction, Application and Specification
  • 8.3.3 Cochlear Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 ImThera
  • 8.4.1 ImThera Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.4.2 ImThera Product Introduction, Application and Specification
  • 8.4.3 ImThera Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 MED-EL
  • 8.5.1 MED-EL Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.5.2 MED-EL Product Introduction, Application and Specification
  • 8.5.3 MED-EL Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Neurelec
  • 8.6.1 Neurelec Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.6.2 Neurelec Product Introduction, Application and Specification
  • 8.6.3 Neurelec Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Boston Scientific
  • 8.7.1 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.7.2 Boston Scientific Product Introduction, Application and Specification
  • 8.7.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 CerebralRx
  • 8.8.1 CerebralRx Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.8.2 CerebralRx Product Introduction, Application and Specification
  • 8.8.3 CerebralRx Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Codman & Shurtleff (Johnson & Johnson)
  • 8.9.1 Codman & Shurtleff (Johnson & Johnson) Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.9.2 Codman & Shurtleff (Johnson & Johnson) Product Introduction, Application and Specification
  • 8.9.3 Codman & Shurtleff (Johnson & Johnson) Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Flowonix
  • 8.10.1 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
  • 8.10.2 Flowonix Product Introduction, Application and Specification
  • 8.10.3 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Inspire Medical Systems
• 8.12 LivaNova (formerly Cyberonics)
• 8.13 Medtronic
• 8.14 Neuronetics
• 8.15 NeuroPace
• 8.16 NeuroSigma
• 8.17 Nurotron
• 8.18 St. Jude Medical

9 Development Trend of Analysis of Neuromodulation Devices and Implantable Infusion Pumps Market

• 9.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Trend Analysis
  • 9.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Neuromodulation Devices and Implantable Infusion Pumps Regional Market Trend
  • 9.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
  • 9.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
  • 9.2.3 China Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
  • 9.2.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
  • 9.2.5 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
  • 9.2.6 India Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
• 9.3 Neuromodulation Devices and Implantable Infusion Pumps Market Trend (Product Type)
• 9.4 Neuromodulation Devices and Implantable Infusion Pumps Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Neuromodulation Devices and Implantable Infusion Pumps Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List